GlassScriptPhysician profile
Gabrielle Uptegraph
NPI 1669105227
$1,575.50
in general payments reported to CMS, 2019-2025
12 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.77 · 2023: $702 · 2024: $422 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,127 · Travel and Lodging: $434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,126.93 |
| Travel and Lodging | $433.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $433.80 | 2023 | Acumed, Innate Implant |
| Stryker Corporation | $402.23 | 2023-2024 | Axs Infinity Ls, Prophecy, Prostep Mica |
| Smith+Nephew, INC. | $237.26 | 2024-2025 | Grafix, Renasys Touch, Pico 7 |
| Exactech, INC. | $145.57 | 2025 | |
| Depuy Synthes Sales INC. | $127.92 | 2023-2024 | Na, Va-Lcp |
| Fusion Orthopedics USA, LLC | $87.27 | 2025 | |
| Novastep INC. | $43.78 | 2025 | Nexis |
| Supreme Orthopedic Systems, LLC | $25.38 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $21.92 | 2024 | Iovera, Exparel |
| Medshape, INC. | $20.21 | 2024 | Dynanail |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.39 | 2023 | Jublia |
| Integra Lifesciences Corporation | $14.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabrielle Uptegraph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.